Andrew Charap

2.0k total citations
2 papers, 60 citations indexed

About

Andrew Charap is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Andrew Charap has authored 2 papers receiving a total of 60 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Immunology, 1 paper in Oncology and 0 papers in Infectious Diseases. Recurrent topics in Andrew Charap's work include Immune Cell Function and Interaction (1 paper), Immunotherapy and Immune Responses (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). Andrew Charap is often cited by papers focused on Immune Cell Function and Interaction (1 paper), Immunotherapy and Immune Responses (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). Andrew Charap collaborates with scholars based in United States. Andrew Charap's co-authors include John P. Sfakianos, Rachel Brody, Tomohiro Enokida, Amir Horowitz, Nina Bhardwaj, Brett A. Miles, Jorge Daza and Peter Wiklund and has published in prestigious journals such as Journal for ImmunoTherapy of Cancer and European Urology Focus.

In The Last Decade

Andrew Charap

2 papers receiving 59 citations

Peers

Andrew Charap
Amanda J. Rode United States
Alla Karpova United States
Jaya Thomas United Kingdom
Andrew Charap
Citations per year, relative to Andrew Charap Andrew Charap (= 1×) peers Takamasa Ishino

Countries citing papers authored by Andrew Charap

Since Specialization
Citations

This map shows the geographic impact of Andrew Charap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Charap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Charap more than expected).

Fields of papers citing papers by Andrew Charap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Charap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Charap. The network helps show where Andrew Charap may publish in the future.

Co-authorship network of co-authors of Andrew Charap

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Charap. A scholar is included among the top collaborators of Andrew Charap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Charap. Andrew Charap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Daza, Jorge, Andrew Charap, Peter Wiklund, & John P. Sfakianos. (2020). Role of the Innate Immune System in the Development, Progression, and Therapeutic Response of Bladder Cancer. European Urology Focus. 6(4). 650–652. 12 indexed citations
2.
Charap, Andrew, Tomohiro Enokida, Rachel Brody, et al.. (2020). Landscape of natural killer cell activity in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(2). e001523–e001523. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026